Lipicard Technologies Survey: U.S. Cardiologists Ready to Prescribe PLATROL(R).TAMPA BAY, Fla. -- Leading Cardiologists during a Lipicard survey said that they will prescribe PLATROL(R) for long-term cardio-protection. Dr. Zacharia P Zacharia, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and President of Fort Lauderdale Heart Institute and Director of Cardiology at Holy Cross Hospital Holy Cross Hospital may refer to: In the United Kingdom:
n.pr See acid, hydroxycitric. Bayonet Point Hospital, Florida, a leading Cardiac Surgeon said most of the interventional cardiologists and cardiologists can offer PLATROL(R) to their patients if the drug is available with less toxicity and higher efficacy. Lipicard survey conducted in Florida also included Dr. Hoshedar P. Tamboli, Cardiologist, University of South Florida • • [ among other leading cardiologists. The Lipicard survey revealed that both Aspirin and Clopidogrel (PLAVIX(R)) are extensively used for general cardio-protection and after cardiovascular intervention -- especially after the angioplasty/insertion of stent. The Cardiologists are aware of non-responders to Aspirin and PLAVIX(R) and said that the response and effectiveness of Aspirin or PLAVIX(R) is not checked. It is well known that all currently available antiplatelet drugs viz- Aspirin, PLAVIX(R), Persantine, Aggrastat, and Ticlid are toxic. The CAPRIE CAPRIE Cardiology A clinical trial–Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events which compared the efficacy of the antiplatelet agent, clopidogrel, with aspirin therapy as a stroke prophylaxis. See Clopidogrel. (1996) study showed that PLAVIX(R) (Clopidogrel) and Aspirin are quite toxic with over 50% of those who take either of them suffer from various toxic side effects. However, the cardiologists said that both Aspirin and PLAVIX(R) are comparatively well tolerated. Mr. Sambaru Prasad, CEO, Lipicard Technologies said, "PLATROL(R) -- The new antiplatelet drug improves the efficacy by 40% over Aspirin and reduces the toxicity to almost nil. And the brief survey of US cardiologists has shown that PLATROL(R) will be well received and prescribed by medicinal and interventional cardiologists." About Lipicard Technologies Lipicard Technologies Limited develops innovative and novel High Therapeutic Index Drugs for Lipid management and cardio protection in collaboration with Life Enhancing Technologies LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control . USA. PLATROL(R) is the first safe antiplatelet drug being developed for cardio-protection. Next in line is the integrated Lipid management drug for increasing HDL (Hardware Description Language) A language used to describe the functions of an electronic circuit for documentation, simulation or logic synthesis (or all three). Although many proprietary HDLs have been developed, Verilog and VHDL are the major standards. and lowering LDL LDL - ["LDL: A Logic-Based Data-Language", S. Tsur et al, Proc VLDB 1986, Kyoto Japan, Aug 1986, pp.33-41]. . PLAVIX(R) and PLATROL(R) are registered trademarks of Sanofi-Synthelabo, and Life Enhancing Technologies respectively. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion